To027 * beta-hydroxybutyrate inhibits nlrp3-mediated inflammation and delays progressive renal failure during primary hyperoxaluria related kidney stone disease
Source: Nephrology Dialysis Transplantation - Category: Urology & Nephrology Authors: Mulay, S. R., Suarez-Alvarez, B., Steiger, S., Honarpisheh, M., Marschner, J., Desai, J., Anders, H.-J. Tags: NEPHROLITHIASIS AND DIVALENT IONS Source Type: research
More News: Dialysis | Kidney Stones | Kidney Transplant | Kidney Transplantation | Renal Failure | Transplants | Urology & Nephrology